Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance Study
The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nosocomial bloodstream infections (BSIs) are important causes of morbidity and mortality in the United States. METHODS: Data from a nationwide, concurrent surveillance study (Surveillance and Control of Pathogens of Epidemiological Importance [SCOPE]) were used to examine the secular trends in the epidemiology and microbiology of nosocomial BSIs. RESULTS: Our study detected 24,179 cases of nosocomial BSI in 49 US hospitals over a 7-year period from March 1995 through September 2002 (60 cases per 10,000 hospital admissions). Eighty-seven percent of BSIs were monomicrobial. Gram-positive organisms caused 65% of these BSIs, gram-negative organisms caused 25%, and fungi caused 9.5%. The crude mortality rate was 27%. The most-common organisms causing BSIs were coagulase-negative staphylococci (CoNS) (31% of isolates), Staphylococcus aureus (20%), enterococci (9%), and Candida species (9%). The mean interval between admission and infection was 13 days for infection with Escherichia coli, 16 days for S. aureus, 22 days for Candida species and Klebsiella species, 23 days for enterococci, and 26 days for Acinetobacter species. CoNS, Pseudomonas species, Enterobacter species, Serratia species, and Acinetobacter species were more likely to cause infections in patients in intensive care units (P<.001). In neutropenic patients, infections with Candida species, enterococci, and viridans group streptococci were significantly more common. The proportion of S. aureus isolates with methicillin resistance increased from 22% in 1995 to 57% in 2001 (P<.001, trend analysis). Vancomycin resistance was seen in 2% of Enterococcus faecalis isolates and in 60% of Enterococcus faecium isolates. CONCLUSION: In this study, one of the largest multicenter studies performed to date, we found that the proportion of nosocomial BSIs due to antibiotic-resistant organisms is increasing in US hospitals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States and elsewhere, Candida species are a leading cause of health care–associated bloodstream infections (3–5).”
From Population-Based Active Surveillance for Culture-Confirmed Candidemia — Four Sites, United States, 2012–2016 (2019) · cites this paper as [4]
In the citing paper
“The incidence of nosocomial candidiasis has increased over the past few decades [28,29,30,31,32].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Candidaemia is the most common form of invasive candidiasis associated with an unacceptably high mortality rates in excess of 40% even with the introduction of newer antifungal agents [30,32,33].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [32]
In the citing paper
“Data from a US surveillance study found that over a 7year period Candida spp.accounted for 4.6 bloodstream infections per 10,000 admissions and 9% of all bloodstream infections [1], whereas the incidence may vary between centers.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
In the citing paper
“Among documented invasive fungal infections, candidemia and invasive candidiasis are encountered with increasing incidence in nosocomial settings [1].”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [1]
11 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · cited 1×
“[30] showed that mortality rates doubled, from 30% to 60%, when inappropriate empirical antibiotic therapy was given to ICU patients with BSIs.”
BackgroundNosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis
Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., & Wenzel, R. P. (1999) · Clinical Infectious Diseases · doi:10.1086/520192 · Cited by 1,387 · cited 3×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundMethodSelf-citationDiekema, D. J., Pfaller, M. A., Schmitz, F. J., Smayevsky, J., Bell, J., Jones, R. N., Beach, M., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,362 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundWeinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228 · cited 1×
“Recent studies have shown that the proportion of contaminants is lower if 2 or more positive blood culture results (of samples drawn within a few hours of each other) were required for inclusion [9, 32, 33].”
BackgroundPittet, D. (1994) · JAMA · doi:10.1001/jama.1994.03510440058033 · Cited by 926
Trick, W. E., Fridkin, S. K., Edwards, J. R., Hajjeh, R. A., Gaynes, R. P., & Hospitals, T. N. N. I. S. S. (2002) · Clinical Infectious Diseases · doi:10.1086/342300 · Cited by 660
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595 · cited 1×
“The crude rate mortality ranged from 12% in total hospital populations to 80% in ICU patients [6–10].”
BackgroundEmergence of Vancomycin Resistance in Coagulase-Negative Staphylococci
Schwalbe, R. S., Stapleton, J. T., & Gilligan, P. H. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704093161507 · Cited by 584 · cited 1×
“In addition, antibiotic resistance rates have been rising during the past 2 decades for all predominant organisms, including Staphylococcus aureus [14, 16, 17], coagulase-negative staphylococci [18, 19], enterococci [20], and gram-negative pathogens [15, 21, 22].”
BackgroundFridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, Jr., Archibald, L. K., Gaynes, R. P., & Tenover, F. C. (1999) · Clinical Infectious Diseases · doi:10.1086/520193 · Cited by 486
Research works printed but not linked: 1
- 1996, 77, 791, 10.1002/(SICI)1097-0142(19960215)77:4<791::AID-CNCR27>3.0.CO;2-V · DOI · Paper page
Cited by
Items 201–300 of 1,033
Bacteremias: A Leading Cause of Death
Bearman, G. M. L., & Wenzel, R. P. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.02.005 · Cited by 220
“Bloodstream infections caused b coagulase-negative staphylococci, Pseudomonasspecies, Enterobacterspecies,Serratia species andAcinetobacter species were seen in the intensive care unit population (2).”
InfluentialSelf-citationChávez, V., Mohri-Shiomi, A., Maadani, A., Vega, L. A., & Garsin, D. A. (2007) · Genetics · doi:10.1534/genetics.107.072587 · Cited by 213
“This human pathogen is among the top three leading causes of hospital-acquired infection and is very problematic because it commonly carries and spreads antibiotic-resistance determinants (Wisplinghoff et al. 2004).”
BackgroundCandida Urinary Tract Infections—Treatment
Fisher, J. F., Sobel, J. D., Kauffman, C. A., & Newman, C. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir112 · Cited by 215
“Moreover, Candida spp are the fourth most common isolates from blood cultures among hospitalized patients [11].”
Recent Advances on Electrochemical Biosensing Strategies toward Universal Point‐of‐Care Systems
Dai, Y., & Liu, C. C. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901879 · Cited by 216
The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril!
Thomson, J. M., & Bonomo, R. A. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.08.014 · Cited by 212
Smeekens, S. P., Ng, A., Kumar, V., Johnson, M. D., Plantinga, T. S., van Diemen, C., Arts, P., Verwiel, E. T. P., Gresnigt, M. S., Fransen, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms2343 · Cited by 213
Candida infective endocarditis
Baddley, J. W., Benjamin, D. K., Patel, M., Miró, J., Athan, E., Barsic, B., Bouza, E., Clara, L., Elliott, T., Kanafani, Z., et al. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0466-x · Cited by 213
“The increase in hospital-acquired Candida IE, in general, is consistent with recent data describing Candida as an emerging nosocomial bloodstream pathogen over the past decade [19].”
ResultPerlroth, J., Kuo, M., Tan, J., Bayer, A. S., & Miller, L. G. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.8.805 · Cited by 212
Conlan, S., Mijares, L. A., Program, N. C. S., Becker, J., Blakesley, R. W., Bouffard, G. G., Brooks, S., Coleman, H., Gupta, J., Gurson, N., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-7-r64 · Cited by 214
“This complicates the decision of whether to treat with antibiotics, remove the medical device, or wait-and-see, any of which can extend the patient’s hospital stay [4].”
Pinholt, M., Østergaard, C., Arpi, M., Bruun, N. E., Schønheyder, H. C., Gradel, K. O., Søgaard, M., & Knudsen, J. D. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12236 · Cited by 209
“4% of the bacteraemias [1].”
Abe, R., Oda, S., Sadahiro, T., Nakamura, M., Hirayama, Y., Tateishi, Y., Shinozaki, K., & Hirasawa, H. (2010) · Critical Care · doi:10.1186/cc8898 · Cited by 211
“Although large-scale surveillance studies of bacterial species causing bacteremia have been published [7,8], the pathophysiological differences in bacteremias with different causative bacterial species remain unclear.”
BackgroundAcquired bloodstream infection in the intensive care unit: incidence and attributable mortality
Prowle, J. R., Echeverri, J. E., Ligabo, E. V., Sherry, N., Taori, G. C., Crozier, T. M., Hart, G. K., Korman, T. M., Mayall, B. C., Johnson, P. D., et al. (2011) · Critical Care · doi:10.1186/cc10114 · Cited by 208
“Critically ill patients are particularly vulnerable to hospital-acquired infections [2,3], which are two to seven times more common in the ICU [4-7] and can account for approximately half of all hospital-acquired BSI [8].”
BackgroundCandida parapsilosis Is a Significant Neonatal Pathogen: A Systematic Review and Meta-analysis
Pammi, M., Holland, L., Butler, G., Gacser, A., & Bliss, J. M. (2013) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3182863a1c · Cited by 206
“Candida is the third most common etiologic agent in late-onset neonatal sepsis (>72 hours of age) and is responsible for 8% to 15% of hospital-acquired infections.(2) Candida infections are responsible for an “attributable mortality” of 18–25%, significant morbidity and healthcare costs.”
BackgroundEpidemiology of candidemia in intensive care units
Bouza, E., & Muñoz, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70006-2 · Cited by 207
Cappelletty, D., & Eiselstein‐McKitrick, K. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.369 · Cited by 205
Bateman, B. T., Schmidt, U., Berman, M. F., & Bittner, E. A. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181cea3d0 · Cited by 204
“During the past decade, there has been a substantial increase in the incidence of severe sepsis in the general population,(1,3,4) along with an increase in the rates of antibiotic resistance in nosocomial infections.(9,10) There has also been an increased understanding of factors contributing to nosocomial infection a…”
BackgroundKean, R., Rajendran, R., Haggarty, J., Townsend, E. M., Short, B., Burgess, K. E., Lang, S., Millington, O., Mackay, W. G., Williams, C., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00258 · Cited by 195
“Biofilms were formed at 37◦C over 1.5 (90 min), 6 and 24 h by adding both organisms 1:1 to either microtiter plates (Corning, NY, USA) or 13 mm diameter ThermanoxTM coverslips (Fisher Scientific, Loughborough, UK), depending on the assay function.”
BackgroundInfluentialCerca, N., Jefferson, K. K., Oliveira, R., Pier, G. B., & Azeredo, J. (2006) · Infection and Immunity · doi:10.1128/iai.00230-06 · Cited by 202
“Staphylococcus epidermidis and other coagulase-negative staphylococci are among the most frequent causes of nosocomial infections (29, 41) and are often associated with the use of medical devices (38).”
BackgroundInhibition of gold nanoparticles (AuNPs) on pathogenic biofilm formation and invasion to host cells
Yu, Q., Li, J., Zhang, Y., Wang, Y., Liu, L., & Li, M. (2016) · Scientific Reports · doi:10.1038/srep26667 · Cited by 201
YEASTRACT+: a portal for cross-species comparative genomics of transcription regulation in yeasts
Monteiro, P. T., Oliveira, J., Pais, P., Antunes, M., Palma, M., Cavalheiro, M., Galocha, M., Godinho, C. P., Martins, L. C., Bourbon, N., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz859 · Cited by 216
“Candida species, on the other hand, are responsible for more than 400 000 life-threatening infections worldwide every year, being recognized as the fourth most common cause of nosocomial infections (8).”
BackgroundSherrington, S. L., Sorsby, E., Mahtey, N., Kumwenda, P., Lenardon, M. D., Brown, I., Ballou, E. R., MacCallum, D. M., & Hall, R. A. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006403 · Cited by 202
“The opportunistic fungal pathogen Candida albicans is a commensal in up to 80% of 60 the population, and can cause superficial mucosal infections in healthy individuals (1, 61 2) and invasive disease in immune supressed patients (3, 4).”
BackgroundWisplinghoff, H., Paulus, T., Lugenheim, M., Stefanik, D., Higgins, P. G., Edmond, M. B., Wenzel, R. P., & Seifert, H. (2012) · Journal of Infection · doi:10.1016/j.jinf.2011.12.008 · Cited by 200
Self-citationHoban, D. J., Bouchillon, S. K., Johnson, B. M., Johnson, J. L., & Dowzicky, M. J. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.06.001 · Cited by 204
“E-mail address: dhoban@ihmainc.com (D.J. Hoban). resistant Staphylococcus aureus (MRSA) and vancomy- cin-resistant Enterococcus spp. (VRE) have been well documented (Wisplinghoff et al., 2004).”
Toda, M., Williams, S. R., Berkow, E. L., Farley, M. M., Harrison, L. H., Bonner, L., Marceaux, K. M., Hollick, R., Zhang, A. Y., Schaffner, W., et al. (2019) · MMWR Surveillance Summaries · doi:10.15585/mmwr.ss6808a1 · Cited by 198
Signalling and oxidant adaptation in Candida albicans and Aspergillus fumigatus
Chauhan, N., Latge, J.-P., & Calderone, R. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1426 · Cited by 199
Automated Interpretation of Blood Culture Gram Stains by Use of a Deep Convolutional Neural Network
Smith, K. P., Kang, A. D., & Kirby, J. E. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01521-17 · Cited by 188
“Bloodstream infections (BSI) are rapidly progressive infections with mortality rates up to nearly 40% (1, 2).”
BackgroundRisk factors for candidemia: a prospective matched case-control study
FUNGINOS, T., Poissy, J., Groups, A. F. S., Damonti, L., Bignon, A., Khanna, N., Von Kietzell, M., Boggian, K., Neofytos, D., Vuotto, F., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2766-1 · Cited by 188
Enterococcus faecalis inhibits hyphal morphogenesis and virulence of Candida albicans
Cruz, M. R., Graham, C. E., Gagliano, B. C., Lorenz, M. C., & Garsin, D. A. (2013) · Infection and Immunity · doi:10.1128/iai.00914-12 · Cited by 188
Maira-Litrán, T., Kropec, A., Goldmann, D. A., & Pier, G. B. (2005) · Infection and Immunity · doi:10.1128/iai.73.10.6752-6762.2005 · Cited by 190
“Staphylococcus aureus and coagulase-negative staphylococci (CoNS), principally Staphylococcus epidermidis, are the most frequent causes of hospital acquired bloodstream infections accounting for 40 to 60% of all nosocomial bloodstream infections (52).”
BackgroundMicrobiology and immunology of fish larvae
Vadstein, O., Bergh, Ø., Gatesoupe, F., Galindo‐Villegas, J., Mulero, V., Picchietti, S., Scapigliati, G., Makridis, P., Olsen, Y., Dierckens, K., et al. (2013) · Reviews in Aquaculture · doi:10.1111/j.1753-5131.2012.01082.x · Cited by 183
“Studies of the human intestinal microbiota show that many of the species comprising smaller populations in the intestine, including E. coli and Staphylococcus aureus, are known to play a significant role in health (Wislinghoff et al. 2004).”
BackgroundComparison of echinocandin antifungals
Eschenauer, G., DePestel, D. D., & Carver, P. L. (2007) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.2007.3.1.71 · Cited by 186
“…the incidence of invasive fungal infections has increased over the past 2 decades, such that Candida species are now the 4th most prevalent causative agent of nosocomial bloodstream infections (Wisplinghoff et al 2004), and infections caused by Aspergillus spp. are also increasing rapidly.”
Tomalka, J., Ganesan, S., Azodi, E., Patel, K., Majmudar, P., Hall, B. A., Fitzgerald, K. A., & Hise, A. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002379 · Cited by 184
“has now been identified as the leading cause of fatal fungal infections, with mortality rates as high as 50%, and ranks 4th among all pathogens isolated from bloodstream and nosocomial infections”
BackgroundCandida glabrata Fungemia: Experience in a Tertiary Care Center
Malani, A., Hmoud, J., Chiu, L., Carver, P. L., Bielaczyc, A., & Kauffman, C. A. (2005) · Clinical Infectious Diseases · doi:10.1086/432939 · Cited by 184
“In intensive care units (ICUs), infection with Candida species is the third most frequent cause of nosocomial bloodstream infection and is associated with a crude mortality rate of 47% [1].”
BackgroundVediyappan, G., Rossignol, T., & d'Enfert, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01638-09 · Cited by 183
Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework
Jabra-Rizk, M. A., Kong, E. F., Tsui, C., Nguyen, M. H., Clancy, C. J., Fidel, P. L., & Noverr, M. (2016) · Infection and Immunity · doi:10.1128/iai.00469-16 · Cited by 182
Candidiasis: Red and White Manifestations in the Oral Cavity
Hellstein, J. W., & Marek, C. L. (2019) · Head and Neck Pathology · doi:10.1007/s12105-019-01004-6 · Cited by 175
Treatment-related risk factors for hospital mortality in Candida bloodstream infections
Labelle, A. J., Micek, S. T., Roubinian, N., & Kollef, M. H. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818b3477 · Cited by 181
Procalcitonin as a Marker for the Detection of Bacteremia and Sepsis in the Emergency Department
Riedel, S., Melendez, J. H., An, A. T., Rosenbaum, J. E., & Zenilman, J. M. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp1mfyinqlecv2 · Cited by 183
Gazendam, R. P., van Hamme, J. L., Tool, A. T. J., van Houdt, M., Verkuijlen, P. J. J. H., Herbst, M., Liese, J. G., van de Veerdonk, F. L., Roos, D., van den Berg, T. K., et al. (2014) · Blood · doi:10.1182/blood-2014-01-551473 · Cited by 181
Spellberg, B. J., Ibrahim, A. S., Avanesian, V., Fu, Y., Myers, C., Phan, Q. T., Filler, S. G., Yeaman, M. R., & Edwards, Jr. (2006) · The Journal of Infectious Diseases · doi:10.1086/504691 · Cited by 180
Charles, P. E., Ladoire, S., Aho, S., Quenot, J.-P., Doise, J.-M., Prin, S., Olsson, N.-O., & Blettery, B. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-38 · Cited by 180
“Background Bacteremia has long been associated with severity of illness, especially in an ICU setting [1,2].”
Best Practices of Blood Cultures in Low- and Middle-Income Countries
Ombelet, S., Barbé, B., Affolabi, D., Ronat, J.-B., Lompo, P., Lunguya, O., Jacobs, J., & Hardy, L. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00131 · Cited by 175
Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface
Moyes, D. L., Richardson, J. P., & Naglik, J. R. (2015) · Virulence · doi:10.1080/21505594.2015.1012981 · Cited by 179
“Given the immunocompromised state of many hospital patients, this has led to Candida infections being the 3rd or 4th most common nosocomial bloodstream infection.(13,14) Given this ever-increasing prevalence of Candida infections, it is therefore important to understand the events that occur during host-Candida intera…”
BackgroundCandida auris: Disinfectants and Implications for Infection Control
Ku, T. S. N., Walraven, C. J., & Lee, S. A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00726 · Cited by 177
“krusei are the Candida species that have been reported to cause over 95% of the cases of invasive candidiasis (Edmond et al., 1999; Wisplinghoff et al., 2004; Falagas et al., 2010; Pfaller et al., 2011; Andes et al., 2016; Strollo et al., 2016).”
BackgroundInvasive Fungal Infections in the ICU: How to Approach, How to Treat
Paramythiotou, E., Frantzeskaki, F., Flevari, A., Armaganidis, A., & Dimopoulos, G. (2014) · Molecules · doi:10.3390/molecules19011085 · Cited by 175
“Though the crude mortality varies between studies, most authors report high percentages (39%–60%) and excess financial burden [11,22].”
BackgroundStaphylococcus aureus (Including Staphylococcal Toxic Shock)
QUE, Y.-A., & MOREILLON, P. (2010) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-0-443-06839-3.00195-8 · Cited by 172
Böll, B., Schalk, E., Buchheidt, D., Hasenkamp, J., Kiehl, M., Kiderlen, T. R., Kochanek, M., Koldehoff, M., Kostrewa, P., Claßen, A. Y., et al. (2021) · Annals of Hematology · doi:10.1007/s00277-020-04286-x · Cited by 166
Sathe, N., Beech, P., Croft, L., Suphioglu, C., Kapat, A., & Athan, E. (2023) · Infectious Medicine · doi:10.1016/j.imj.2023.05.003 · Cited by 160
“Wisplinghoff et al. [89] published a nation-wide surveillance study on nosocomial BSI in the USA and reported P. aeruginosa as the third most common Gram-negative bacteria causing nosocomial BSI and accounted for 4.3% of all cases.”
BackgroundInfluentialMelo, A. S., Bizerra, F. C., Freymüller, E., Arthington-Skaggs, B. A., & Colombo, A. L. (2011) · Medical Mycology · doi:10.3109/13693786.2010.530032 · Cited by 175
Master and Commander in Fungal Pathogens: the Two-Component System and the HOG Signaling Pathway
Bahn, Y.-S. (2008) · Eukaryotic Cell · doi:10.1128/ec.00323-08 · Cited by 176
Ramírez, M. A., & Lorenz, M. C. (2007) · Eukaryotic Cell · doi:10.1128/ec.00372-06 · Cited by 174
“Disseminated hematogenous candididasis, the most severe manifestation, is the fourth most common hospital-acquired infection and has a mortality rate of about 40% (50).”
BackgroundVylkova, S., & Lorenz, M. C. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003995 · Cited by 174
“rate of about 40% [3,4].”
Forrest, G. N., Roghmann, M.-C., Toombs, L. S., Johnson, J. K., Weekes, E., Lincalis, D. P., & Venezia, R. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00283-08 · Cited by 175
“The predominant enterococcal species that cause these infections are Enterococcus faecalis and Enterococcus faecium (28, 38).”
BackgroundActive Surveillance of Candidemia, Australia
Chen, S., Slavin, M., Nguyen, Q., Marriott, D., Playford, E. G., Ellis, D., Sorrell, T., & Study, T. A. C. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1210.060389 · Cited by 174
Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1338-7 · Cited by 173
“varies depending on the population surveyed [1, 2].”
BackgroundInfluentialThe metabolic basis of Candida albicans morphogenesis and quorum sensing.
Han, T.-L., Cannon, R. D., & Villas-Bôas, S. G. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2011.04.002 · Cited by 173
“C. albicans is the fourth leading cause of nosocomial bloodstream infections (Pfaller and Diekema, 2007), with an attributable mortality of 37–44% in severely immunocompromised patients (Wisplinghoff et al., 2004; Leroy et al., 2009; Moran et al., 2010).”
Harriott, M. M., & Noverr, M. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00573-10 · Cited by 172
“albicans is the 4th leading cause of bloodstream infections and the 3rd most common organism isolated from intravascular catheters and is associated with the highest incidence of mortality (11, 32).”
BackgroundSurveillance Cultures and Duration of Carriage of Multidrug-Resistant Acinetobacter baumannii
Marchaim, D., Navon-Venezia, S., Schwartz, D., Tarabeia, J., Fefer, I., Schwaber, M. J., & Carmeli, Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02424-06 · Cited by 175
“The International Network for the Study and Prevention of Emerging Antimicrobial Resistance defined the emergence of carbapenem resistance in Acinetobacter baumannii infections as a “global sentinel event” warranting prompt epidemiological and microbiological interventions (30).”
BackgroundNon-leaching surfaces capable of killing microorganisms on contact
Ferreira, L., & Zumbuehl, A. (2009) · Journal of Materials Chemistry · doi:10.1039/b905668h · Cited by 175
The fungal cell wall as a target for the development of new antifungal therapies
Cortés, J. C. G., Curto, M.-Á., Carvalho, V. S. D., Pérez, P., & Ribas, J. C. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.02.008 · Cited by 170
Molecular Mechanisms of Ethanol-Induced Pathogenesis Revealed by RNA-Sequencing
Camarena, L., Bruno, V., Euskirchen, G., Poggio, S., & Snyder, M. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000834 · Cited by 171
“Nosocomial and community acquired infections are associated with a wide spectrum of clinical manifestations, including pneumonia (the most frequent pathology associated with this microorganism), urinary tract infections, bacteremia and meningitis [4-7].”
BackgroundPrevalence of multidrug-resistant organisms recovered at a military burn center
Keen, E. F., Robinson, B. J., Hospenthal, D. R., Aldous, W. K., Wolf, S. E., Chung, K. K., & Murray, C. K. (2010) · Burns · doi:10.1016/j.burns.2009.10.013 · Cited by 170
“aureus was identified as the second most common isolate recovered from patients with bloodstream infections in US hospitals and the surveillance data indicated 41% of tested isolates were methicillin-resistant [22].”
BackgroundWiderström, M., Wiström, J., Sjöstedt, A., & Monsen, T. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1270-6 · Cited by 169
“CoNS are the most common cause of nosocomial bloodstream infection, responsible for approximately 30% of these infections [2].”
BackgroundEl Zowalaty, M. E., Al Thani, A. A., Webster, T. J., El Zowalaty, A. E., Schweizer, H. P., Nasrallah, G. K., Marei, H. E., & Ashour, H. M. (2015) · Future Microbiology · doi:10.2217/fmb.15.48 · Cited by 169
Thaden, J. T., Park, L. P., Maskarinec, S. A., Ruffin, F., Fowler, V. G., & van Duin, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02671-16 · Cited by 168
“0001 Pneumonia 39 (25) 192 (8) Urine/pyelonephritis 30 (19) 488 (20) Abscess 6 (4) 112 (4) Line associated 14 (9) 436 (17) Skin/soft tissue 10 (6) 249 (10) Biliary tract 4 (3) 95 (4) Other 21 (13) 357 (14) Source not identified 34 (22) 572 (23)”
Biofilm formation in medically important Candida species
Malinovská, Z., Čonková, E., & Váczi, P. (2023) · Journal of Fungi · doi:10.3390/jof9100955 · Cited by 167
“Some studies have confirmed high mortality in C. krusei (40–59%), especially in patients with neutropenia and hematologic malignancies [35,36].”
Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity
Choi, C. H., Hyun, S. H., Lee, J. Y., Lee, J. S., Lee, Y. S., Kim, S. A., Chae, J.-P., Yoo, S. M., & Lee, J. C. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01041.x · Cited by 166
“…with human infections and is of great concern in a clinical setting because of its multiple antibiotic resistance and high mortality among infected patients (Gudiol, 2000; Corbella et al., 2001; Kuo et al., 2004; Wisplinghoff et al., 2004; Abbott, 2005; Chen et al., 2005; Taccone et al., 2006).”
BackgroundBalli, E. P., Venetis, C. A., & Miyakis, S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01289-13 · Cited by 167
Emergence of coagulase-negative staphylococci
Becker, K., Both, A., Weißelberg, S., Heilmann, C., & Rohde, H. (2020) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2020.1730813 · Cited by 159
Virulence Factors in Coagulase-Negative Staphylococci
França, Â., Gaio, V., Lopes, N., & Melo, L. D. R. (2021) · Pathogens · doi:10.3390/pathogens10020170 · Cited by 182
“devices and are especially associated with the use of intravascular catheters or implant ports [454,455].”
BackgroundUpdate on Coagulase-Negative Staphylococci—What the Clinician Should Know
Michels, R., Last, K., Becker, S. L., & Papan, C. (2021) · Microorganisms · doi:10.3390/microorganisms9040830 · Cited by 166
“CoNS represented 31% among all cases of nosocomial BSI within a period of 7 years in a total of 49 US hospitals [15].”
BackgroundClancy, C. J., Pappas, P. G., Vazquez, J., Judson, M. A., Kontoyiannis, D. P., Thompson, G. R., Garey, K. W., Reboli, A., Greenberg, R. N., Apewokin, S., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1095 · Cited by 165
“Candida species are among the most common causes of nosocomial bloodstream infections [1, 2].”
BackgroundStaphylococcus aureus Bloodstream Infections: Definitions and Treatment
Corey, G. R. (2009) · Clinical Infectious Diseases · doi:10.1086/598186 · Cited by 166
“aureus is a leading cause of bacteremia [5, 6] and”
BackgroundBen-Ami, R., Garcia-Effron, G., Lewis, R. E., Gamarra, S., Leventakos, K., Perlin, D. S., & Kontoyiannis, D. P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir351 · Cited by 162
“Candida species are the most common fungal pathogens in humans and are responsible for a spectrum of diseases ranging from mucosal infections to life-threatening invasive candidiasis [1].”
BackgroundLaurita, R., Barbieri, D., Gherardi, M., Colombo, V., & Lukes, P. (2015) · Clinical Plasma Medicine · doi:10.1016/j.cpme.2015.10.001 · Cited by 163
Bain, J. M., Louw, J., Lewis, L. E., Okai, B., Walls, C. A., Ballou, E. R., Walker, L. A., Reid, D., Munro, C. A., Brown, A. J. P., et al. (2014) · mBio · doi:10.1128/mbio.01874-14 · Cited by 160
“Candida species represent the fourth most frequent cause of bloodstream infection in hospitalized patients, with mortality in 40% of cases, even when antifungal therapy is administered (1).”
BackgroundMorata, L., Cobos-Trigueros, N., Martínez, J. A., Soriano, Á., Almela, M., Marco, F., Sterzik, H., Núñez, R., Hernández, C., & Mensa, J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00750-12 · Cited by 163
“Pseudomonas aeruginosa is one of the leading causes of nosocomial bloodstream infections and the third most frequent cause of Gram-negative infections in the United States (31).”
BackgroundSafety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults
Sandison, T., Ong, V., Lee, J., & Thye, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01627-16 · Cited by 161
Fungal PDR transporters: Phylogeny, topology, motifs and function
Lamping, E., Baret, P. V., Holmes, A. R., Monk, B. C., Goffeau, A., & Cannon, R. D. (2010) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2009.10.007 · Cited by 162
“The authors gratefully acknowledge funding from the National Institutes of Health, USA (R01DE016885-01), and the Foundation for Research Science and Technology of New Zealand (IIOF grant UOOX0607).”
BackgroundColombo, A. L., Guimarães, T., Silva, L. R. B. F., Monfardini, L. P. D. A., Cunha, A. K. B., Rady, P., Alves, T., & Rosas, R. C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/513615 · Cited by 162
“1086/513615 The incidence rates of candidemia in tertiary care hospitals increased substantially throughout the 1980s in different regions of the world.(1) Despite all the information available on the epidemiology of candidemia and the new developments achieved in the diagnosis of fungal infection and antifungal thera…”
BackgroundKaye, K. S., Marchaim, D., Chen, T., Baures, T., Anderson, D. J., Choi, Y., Sloane, R., & Schmader, K. E. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12634 · Cited by 161
Jones, C. J., Newsom, D., Kelly, B., Irie, Y., Jennings, L. K., Xu, B., Limoli, D. H., Harrison, J. J., Parsek, M. R., White, P., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003984 · Cited by 161
“aeruginosa, with mortality rates approaching 40% in patients with bacteremia [1,2].”
Quorum sensing in Acinetobacter: an emerging pathogen
Bhargava, N., Sharma, P., & Capalash, N. (2010) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2010.512269 · Cited by 158
“…baumannii ICU acquired pneumonia Gaynes et al., 2005 Community acquired pneumonia Anstey et al., 2002 Leung et al., 2006 Blood stream infection Wisplinghoff et al., 2004 Fournier and Richet, 2006 Skin/soft tissue infection Gaynes et al., 2006 Trottier et al., 2007 Wounds of combat…”
BackgroundOstrosky-Zeichner, L., Shoham, S., Vazquez, J., Reboli, A., Betts, R., Barron, M. A., Schuster, M., Judson, M. A., Revankar, S. G., Caeiro, J. P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu074 · Cited by 160
“Invasive candidiasis (IC) is the third most common bloodstream infection in the intensive care unit (ICU) and is independently associated with mortality [1, 2].”
BackgroundStaphylococcus aureus infection induces protein A–mediated immune evasion in humans
Pauli, N. T., Kim, H. K., Falugi, F., Huang, M., Dulac, J., Henry Dunand, C., Zheng, N.-Y., Kaur, K., Andrews, S. F., Huang, Y., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20141404 · Cited by 155
“In the United States, >20% of all blood infections diagnosed in hospitals are S. aureus infections (Wisplinghoff et al., 2004).”
BackgroundTavares-Carreón, F., de Anda-Mora, K., Rojas‐Barrera, I. C., & Andrade, Á. (2023) · PeerJ · doi:10.7717/peerj.14399 · Cited by 170
Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy
Wurtele, H., Tsao, S., Lépine, G., Mullick, A., Tremblay, J., Drogaris, P., Lee, E.-H., Thibault, P., Verreault, A., & Raymond, M. (2010) · Nature Medicine · doi:10.1038/nm.2175 · Cited by 157
Rodríguez-Baño, J., Picón, E., Gijón, P., Hernández, J. R., Cisneros, J. M., Peña, C., Almela, M., Almirante, B., Grill, F., Colomina, J., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02353-09 · Cited by 156
“Gram-negative organisms are an important cause of nosocomial bloodstream infections (BSIs) (33), particularly when the source of the BSI is the urinary, respiratory, or gastrointestinal tract.”
BackgroundShih, P.-Y., Liao, Y.-T., Tseng, Y.-K., Deng, F.-S., & Lin, C.-H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00602 · Cited by 156
“Chitosan has been widely used in many biomedical and agricultural applications and in the food, water treatment, and cosmetics industries (Shahidi et al., 1999; Kumar, 2000; Haque et al., 2005; Kim et al., 2005; Yamada et al., 2005; Azuma et al., 2015; Cheung et al., 2015).”
BackgroundImpact of Multidrug-Resistant Pseudomonas aeruginosa Bacteremia on Patient Outcomes
Tam, V. H., Rogers, C. A., Chang, K., Weston, J. S., Caeiro, J., & Garey, K. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00207-10 · Cited by 155
“The crude mortality rate exceeded 38%, and the intensive care unit-related mortality was nearly 50% (20).”
BackgroundShepard, J. R., Addison, R. M., Alexander, B. D., Della‐Latta, P., Gherna, M., Haase, G., Hall, G. S., Johnson, J. K., Merz, W. G., Peltroche‐Llacsahuanga, H., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01385-07 · Cited by 170
Impact of Staphylococcus aureus on Pathogenesis in Polymicrobial Infections
Nair, N., Biswas, R., Götz, F., & Biswas, L. (2014) · Infection and Immunity · doi:10.1128/iai.00059-14 · Cited by 155
“aureus represents a significant therapeutic challenge, and their coisolation from blood is an indication of a dire prognosis (42).”
BackgroundStaphylococcus aureus bacteremia in patients with prosthetic devices: Costs and outcomes
Chu, V. H., Crosslin, D. R., Friedman, J. Y., Reed, S. D., Cabell, C. H., Griffiths, R. I., Masselink, L. E., Kaye, K. S., Corey, G. R., Reller, L. B., et al. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.06.011 · Cited by 160
Weems, J. J., Steinberg, J. P., Filler, S., Baddley, J. W., Corey, G. R., Sampathkumar, P., Winston, L., John, J. F., Kubin, C. J., Talwani, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00096-06 · Cited by 153
“Staphylococcus aureus is a leading cause of healthcare-associated and community-onset bacteremia in the United States and abroad (15, 23, 24).”
BackgroundRisk factors for albicans and non-albicans candidemia in the intensive care unit*
Chow, J. K., Golan, Y., Ruthazer, R., Karchmer, A. W., Carmeli, Y., Lichtenberg, D. A., Chawla, V., Young, J. A., & Hadley, S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31816fc4cd · Cited by 154
“hospitals (1), with increasing numbers of these nosocomial infections occurring in intensive care units (ICUs) (2–4).”
BackgroundKofla, G., & Ruhnke, M. (2011) · European Journal of Medical Research · doi:10.1186/2047-783x-16-4-159 · Cited by 153
“candidaemia has been observed to be the fourth leading cause of bloodstream infections in pediatric patients, cancer patients, and hospitalized patients with mortality rates from 20% in pediatric patients to 47% in intensive care unit patients [3-5].”
BackgroundLee, H.-Y., Chen, C., Wu, S.-R., Huang, C.-W., & Chiu, C. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000125 · Cited by 151
“Critical Care Medicine www.ccmjournal.org 1081 Objectives: Acinetobacter baumannii complex bacteremia has been identified increasingly in critical patients admitted in ICUs.”
BackgroundInfluentialSeifert, H. (2009) · Clinical Infectious Diseases · doi:10.1086/598188 · Cited by 178
Self-citationPatel, S., & Saiman, L. M. (2010) · Clinics in Perinatology · doi:10.1016/j.clp.2010.06.004 · Cited by 172
Antifungal Activity from 14-Helical β-Peptides
Karlsson, A. J., Pomerantz, W. C. K., Weisblum, B., Gellman, S. H., & Palecek, S. P. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064630y · Cited by 151
Metadata
- Authors
- Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B.
- Affiliations
- University of Cologne (DE)
- Virginia Commonwealth University (US)
- Corresponding author
- Edmond, M. B.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-08-01
- Volume
- 39
- Issue
- 3
- Pages
- 309-317
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2171155970
- Cited by
- 4,496
- References
- 42
- Citations by year
- 2026: 78 · 2025: 138 · 2024: 137 · 2023: 171 · 2022: 209 · 2021: 187 · 2020: 229 · 2019: 252 · 2018: 215 · 2017: 238 · 2016: 255 · 2015: 271 · 2014: 291 · 2013: 257 · 2012: 241
- FWCI
- 105.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- nosocomial bloodstream infection, nosocomial infections, antibiotic resistance, methicillin-resistant Staphylococcus aureus, vancomycin resistance, Enterococcus faecium, Enterococcus faecalis, coagulase-negative staphylococci, candidiasis, intensive care unit, neutropenic patients, infectious disease epidemiology, temporal trends
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Candidiasis, Child, Child, Preschool, Cross Infection, Drug Resistance, Microbial, Female, Humans, Infant, Male, Middle Aged, Population Surveillance, Prospective Studies, Staphylococcal Infections, United States, Causality, Incidence, Fungemia, Bacteremia, Gram-Negative Bacterial Infections, Gram-Positive Bacterial Infections, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.